Yüklüyor......
Initial Testing of VNP40101M (Cloretazine(®)) by the Pediatric Preclinical Testing Program
VNP40101M is a novel alkylating agent that yields two reactive compounds (a chloroethylating species and methylisocyanate) and has demonstrated activity against a wide spectrum of tumor xenografts. VNP40101M was tested against an in vivo panel of 5 pediatric brain tumor xenografts at a dose of 18 mg...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836208/ https://ncbi.nlm.nih.gov/pubmed/18493996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21620 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|